KLP Kapitalforvaltning’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
19,700
+2,300
+13% +$96.4K ﹤0.01% 1042
2026
Q1
$560K Buy
17,400
+700
+4% +$25.9K ﹤0.01% 1374
2025
Q4
$703K Sell
16,700
-600
-3% -$24.2K ﹤0.01% 1231
2025
Q3
$594K Buy
17,300
+1,900
+12% +$54.5K ﹤0.01% 1309
2025
Q2
$416K Hold
15,400
– – ﹤0.01% 1453
2025
Q1
$457K Hold
15,400
– – ﹤0.01% 1355
2024
Q4
$610K Buy
+15,400
New +$583K ﹤0.01% 1253

Other funds holding VCYT

KLP Kapitalforvaltning's VCYT Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Veracyte (VCYT) stake by 13% in Q2 2026, buying an estimated $96.4K and bringing the position to 19,700 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

KLP Kapitalforvaltning first reported a position in VCYT in Q4 2024 and has held it in 7 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • KLP Kapitalforvaltning held 19,700 shares of Veracyte worth $1.16M as of Q2 2026.
  • KLP Kapitalforvaltning bought 2,300 Veracyte shares in Q2 2026, an estimated $96.4K.
  • Veracyte made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1042 holding.
  • KLP Kapitalforvaltning first reported a position in Veracyte in Q4 2024 and has held it in 7 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.